Automated homogeneous liposome-based assay system for total complement activity. 1995

S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
Osaka Research Laboratories, Wako Pure Chemical Industries, Ltd., Hyogo, Japan.

We developed an automated homogeneous immunoassay, based on immune lysis of dinitrophenyl (DNP)-labeled liposomes, for measuring total complement activity. Liposome lysis caused by complement activity was detected spectrophotometrically from entrapped glucose-6-phosphate dehydrogenase activity. Complement activity in human sera was quantified by comparison with a calibration curve. For ease of application to fully automated routine clinical analyzers, we adopted a two-reagent system, one reagent containing a homogeneous population of small DNP-labeled liposomes and one containing antibody/substrate. This system required calibration only once a week. Within-run and between-run CVs were 0.4-1.3% (n = 10) and 1.8-4.7% (n = 10), respectively. Serum results were linear upon dilution (with saline) over a twofold range. Bilirubin, hemoglobin, Intrafat, and serum proteins such as rheumatoid factor, M protein, IgG, and IgA did not affect the assay results. The results (y) correlated well with those from a hemolytic complement activity test (x): y = 1.05x - 1.14, r = 0.92, on 66 samples in the range < 10- > 50 kU/L. This method should therefore be of great use for the determination of complement activity.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D004136 Dinitrobenzenes Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. Dinitrobenzene,Dinitrophenyl Compound,Dinitrophenyl Compounds,Dinitrotoluene,Dinitrotoluenes,Compound, Dinitrophenyl

Related Publications

S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
January 2002, Acta medica portuguesa,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
February 1986, Clinical chemistry,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
January 1984, Complement (Basel, Switzerland),
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
January 2014, Vestnik Rossiiskoi akademii meditsinskikh nauk,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
June 1992, Clinical chemistry,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
April 1987, Clinical chemistry,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
July 2004, Clinical chemistry,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
January 1991, Complement and inflammation,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
September 1983, Clinical chemistry,
S Yamamoto, and K Kubotsu, and M Kida, and K Kondo, and S Matsuura, and S Uchiyama, and O Yonekawa, and T Kanno
December 1985, Journal of clinical & laboratory immunology,
Copied contents to your clipboard!